Home › Funds › Saturn V Capital Management LP › OVID

Saturn V Capital Management LP position in OVID

OVID THERAPEUTICS INC · Health Care

Saturn V Capital Management LP reported holding 663,060 shares of OVID (OVID THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.8M, representing 0.26% of its reported portfolio and ranking #23 among its reported holdings. Saturn V Capital Management LP has disclosed OVID holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)663.06K sh
Reported value held$1.78M
Portfolio Weight0.26%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Saturn V Capital Management LP's OVID position evolved

Saturn V Capital Management LP first disclosed a stake in OVID in Q4 2025 at 2,500,000 shares (US$4.1M). The position peaked in Q1 2026 at 4,166,666 shares, worth US$9.2M. Across 3 filings, Saturn V Capital Management LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 663,060 shares valued at US$1.8M — a reduction of -3,503,606 shares quarter over quarter.. Notable position changes include a 67% increase in Q1 2026 (shares rose 21% over the following quarter), a 84% trim in Q2 2026 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.50M $4.08M New
Q1 2026 4.17M $9.25M Add
Q2 2026 663.06K $1.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OVID and 13F data

OVID (OVID THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in OVID — the largest reported positions include Affinity Asset Advisors, LLC (US$27.3M), ADAR1 Capital Management, LLC (US$20.0M), SILVERARC CAPITAL MANAGEMENT, LLC (US$8.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OVID

All OVID fund holders →

FAQ

How long has Saturn V Capital Management LP held OVID?

Saturn V Capital Management LP has disclosed OVID holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Saturn V Capital Management LP's current position in OVID?

As of Q2 2026, Saturn V Capital Management LP holds 663.06K shares of OVID (OVID THERAPEUTICS INC), valued at $1.78M, representing 0.26% of its reported portfolio and ranking #23.

Has Saturn V Capital Management LP been buying or selling OVID?

In the latest 13F filing (Q2 2026), Saturn V Capital Management LP reduced its position in OVID. The position peaked in Q1 2026 at 4.17M shares.

Which other funds hold OVID?

Other major institutional holders of OVID include Affinity Asset Advisors, LLC, ADAR1 Capital Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.